...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Antibodies Against Microglial Receptors TREM2 and CD33 Head to Trials

Alector gets reviewed also . Symbol ALEC. This one is early stage and sports a market cap of 1.3 B US or about 2X ours. They have no other indication so its a comp for our Cognition fraction of BOM !? Added all up we are gravely undervalued in my opinion.

Share
New Message
Please login to post a reply